Literature DB >> 19242342

Caffeine restores myocardial cytochrome oxidase activity and improves cardiac function during sepsis.

Richa Verma1, Zhishan Huang, Clifford S Deutschman, Richard J Levy.   

Abstract

OBJECTIVE: Impaired mitochondrial function is a potential cause of sepsis-associated myocardial depression. Cytochrome oxidase (CcOX), the terminal oxidase of the electron transport chain, is inhibited in the septic heart. Caffeine increases CcOX activity by increasing cyclic adenosine monophosphate and protein kinase A activity. We hypothesized that caffeine will restore myocardial CcOX activity, increase cardiac function, and improve survival during sepsis.
DESIGN: Prospective randomized controlled study.
SETTING: University hospital-based laboratory.
SUBJECTS: One hundred twenty Sprague-Dawley male rats.
INTERVENTIONS: Sprague-Dawley male rats underwent cecal ligation and puncture (CLP) or sham operation. At 24 and 48 hours, rats underwent intraperitoneal injection of either caffeine (7.5 mg/kg, the equivalent of 1-1.5 cups of coffee) or equal volume of saline.
MEASUREMENTS AND MAIN RESULTS: One hour following the 48-hour injection, steady-state CcOX kinetic activity was measured in isolated mitochondria and normalized to citrate synthase activity. Cardiac function was assessed using an isolated rat heart preparation and survival was tracked to 96 hours. CLP significantly decreased myocardial CcOX activity, oxygen consumption, left ventricular pressure, and pressure developed during isovolumic contraction (+dP/dt) and relaxation (-dP/dt). Caffeine restored CcOX activity and increased left ventricular pressure and +/-dP/dt toward sham values following CLP. Survival significantly improved following CLP in caffeine-injected animals compared with saline injection.
CONCLUSION: Caffeine may be a novel therapy to treat sepsis-associated myocardial depression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19242342      PMCID: PMC3970220          DOI: 10.1097/CCM.0b013e31819cecd6

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  28 in total

Review 1.  Cytopathic hypoxia. Is oxygen use impaired in sepsis as a result of an acquired intrinsic derangement in cellular respiration?

Authors:  Mitchell P Fink
Journal:  Crit Care Clin       Date:  2002-01       Impact factor: 3.598

2.  Spectrophotometric assay of cytochrome c oxidase.

Authors:  L SMITH
Journal:  Methods Biochem Anal       Date:  1955

3.  Sepsis induces diaphragm electron transport chain dysfunction and protein depletion.

Authors:  Leigh A Callahan; Gerald S Supinski
Journal:  Am J Respir Crit Care Med       Date:  2005-06-30       Impact factor: 21.405

4.  Differential alterations in cardiovascular responses during the progression of polymicrobial sepsis in the mouse.

Authors:  Shaolong Yang; Chun-Shiang Chung; Alfred Ayala; Irshad H Chaudry; Ping Wang
Journal:  Shock       Date:  2002-01       Impact factor: 3.454

Review 5.  Mitochondrial dysfunction in sepsis.

Authors:  M Singer; D Brealey
Journal:  Biochem Soc Symp       Date:  1999

6.  The A2A adenosine receptor mediates coronary vasodilation.

Authors:  L Belardinelli; J C Shryock; S Snowdy; Y Zhang; A Monopoli; G Lozza; E Ongini; R A Olsson; D M Dennis
Journal:  J Pharmacol Exp Ther       Date:  1998-03       Impact factor: 4.030

Review 7.  Caffeine and other sympathomimetic stimulants: modes of action and effects on sports performance.

Authors:  Gareth Jones
Journal:  Essays Biochem       Date:  2008       Impact factor: 8.000

Review 8.  Caffeine and exercise: metabolism and performance.

Authors:  T E Graham; J W Rush; M H van Soeren
Journal:  Can J Appl Physiol       Date:  1994-06

9.  Mitochondrial Dysfunction in Sepsis.

Authors:  David Brealey; Mervyn Singer
Journal:  Curr Infect Dis Rep       Date:  2003-10       Impact factor: 3.725

Review 10.  Bench-to-bedside review: Cytopathic hypoxia.

Authors:  Mitchell P Fink
Journal:  Crit Care       Date:  2002-09-12       Impact factor: 9.097

View more
  17 in total

1.  Mitochondrial dysfunction and resuscitation in sepsis.

Authors:  Albert J Ruggieri; Richard J Levy; Clifford S Deutschman
Journal:  Crit Care Clin       Date:  2010-07       Impact factor: 3.598

2.  Cardiovascular effects of long-term caffeine administration in aged rats.

Authors:  S M T El Agaty; A A Seif
Journal:  Ir J Med Sci       Date:  2014-03-18       Impact factor: 1.568

3.  Caffeine Improves Heart Rate Without Improving Sepsis Survival.

Authors:  Gustavo Bauzá; Daniel Remick
Journal:  Shock       Date:  2015-08       Impact factor: 3.454

Review 4.  MITOCHONDRIAL FUNCTION IN SEPSIS.

Authors:  Nishkantha Arulkumaran; Clifford S Deutschman; Michael R Pinsky; Brian Zuckerbraun; Paul T Schumacker; Hernando Gomez; Alonso Gomez; Patrick Murray; John A Kellum
Journal:  Shock       Date:  2016-03       Impact factor: 3.454

Review 5.  An Overview on Mitochondrial-Based Therapies in Sepsis-Related Myocardial Dysfunction: Mitochondrial Transplantation as a Promising Approach.

Authors:  Behnaz Mokhtari; Rana Yavari; Reza Badalzadeh; Ata Mahmoodpoor
Journal:  Can J Infect Dis Med Microbiol       Date:  2022-06-06       Impact factor: 2.585

6.  Metabolic resuscitation in sepsis: a necessary step beyond the hemodynamic?

Authors:  Heitor Pons Leite; Lúcio Flávio Peixoto de Lima
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

Review 7.  Caffeine and cardiovascular diseases: critical review of current research.

Authors:  Anthony Zulli; Renee M Smith; Peter Kubatka; Jan Novak; Yoshio Uehara; Hayley Loftus; Tawar Qaradakhi; Miroslav Pohanka; Nazarii Kobyliak; Angela Zagatina; Jan Klimas; Alan Hayes; Giampiero La Rocca; Miroslav Soucek; Peter Kruzliak
Journal:  Eur J Nutr       Date:  2016-03-01       Impact factor: 5.614

8.  Orexinergic activity modulates altered vital signs and pituitary hormone secretion in experimental sepsis.

Authors:  Clifford S Deutschman; Nichelle R Raj; Erin O McGuire; Max B Kelz
Journal:  Crit Care Med       Date:  2013-11       Impact factor: 7.598

Review 9.  Experimental treatments for mitochondrial dysfunction in sepsis: A narrative review.

Authors:  Guilang Zheng; Juanjuan Lyu; Jingda Huang; Dan Xiang; Meiyan Xie; Qiyi Zeng
Journal:  J Res Med Sci       Date:  2015-02       Impact factor: 1.852

10.  Higher platelet cytochrome oxidase specific activity in surviving than in non-surviving septic patients.

Authors:  Leonardo Lorente; María M Martín; Esther López-Gallardo; Ruth Iceta; José Blanquer; Jordi Solé-Violán; Lorenzo Labarta; César Díaz; Alejandro Jiménez; Julio Montoya; Eduardo Ruiz-Pesini
Journal:  Crit Care       Date:  2014-06-30       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.